Titanium MPJ (Toe Implant)TOE JOINT TITANIUM NPC LG, Part ID 16816

FDA Device Recall #Z-0685-2022 — Class II — February 1, 2022

Recall Summary

Recall Number Z-0685-2022
Classification Class II — Moderate risk
Date Initiated February 1, 2022
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm BioPro, Inc.
Location Port Huron, MI
Product Type Devices

Product Description

Titanium MPJ (Toe Implant)TOE JOINT TITANIUM NPC LG, Part ID 16816

Reason for Recall

There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been conducted on the titanium version of the MPJ.

Distribution Pattern

US Nationwide distribution in the states of CT, KY, NM, PA, TN, and SD.

Lot / Code Information

Lot Number: 125672, 128357; UDI: 00810012480116

Other Recalls from BioPro, Inc.

Recall # Classification Product Date
Z-0152-2026 Class II BioPro Endo Head (Ceramic) Product ID/Descri... Sep 9, 2025
Z-0153-2026 Class II BioPro Femoral Head Product ID/Description ... Sep 9, 2025
Z-0148-2026 Class II BioPro Femoral Head (Metal 22, 28, 32, 36, 40) ... Sep 9, 2025
Z-0151-2026 Class II BioPro Femoral Head (Ceramic heads 28-30) Pr... Sep 9, 2025
Z-0149-2026 Class II BioPro Endo Head (Metal uni-polar, 38-55) Pr... Sep 9, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.